Table 3.
Potential place in therapy of delafloxacin
| Empirical therapy |
| Exacerbations of chronic obstructive pulmonary disease |
| Pneumoniaa |
| Intra-abdominal infection (community) |
| Acute bacterial skin and skin structure infections (ABSSSI)b |
| Specific antibiotic therapy |
| Urinary tract infections |
| Bone and joint infections |
| Sequential oral therapy in Staphylococcal bacteremia |
| Sexually transmitted infections |
Notes:
a
Community-acquired pneumonia, hospital-acquired pneumonia and aspirative pneumonia.
b
Primary ABSSSI (cellulitis, abscesses) and secondary ABSSSI (diabetic foot infections, surgical site infections, burns).